• Login
Thursday, April 23, 2026
Geneva Times
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
Home Business

British pharma giant GSK to acquire U.S. drug developer IDRx in $1.15 billion deal

GenevaTimes by GenevaTimes
January 14, 2025
in Business
Reading Time: 1 min read
0
British pharma giant GSK to acquire U.S. drug developer IDRx in .15 billion deal
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter




The biopharmaceutical company’s drug in development is designed to treat gastrointestinal stromal tumors (GIST). Read More

Read More

Previous Post

Queen kept in dark over Palace traitor for years, MI5 papers reveal

Next Post

EU states approve Swiss participation in military project

Next Post
EU states approve Swiss participation in military project

EU states approve Swiss participation in military project

Leave a Reply

Your email address will not be published. Required fields are marked *

ADVERTISEMENT
Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Contact us:

editor@thegenevatimes.ch

Visit us

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin